{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:00:16Z","timestamp":1792058416310,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["Project I 5640-N"],"award-info":[{"award-number":["Project I 5640-N"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["\\u2018deCIPHER\\u2019"],"award-info":[{"award-number":["\\u2018deCIPHER\\u2019"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["221702\/Z\/20\/Z"],"award-info":[{"award-number":["221702\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tibtech.2026.02.022","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:29:22Z","timestamp":1777480162000},"page":"3126-3141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["One-pot expression of an oligoclonal nanobody-based antivenom in growth-decoupled Escherichia coli"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4073-2292","authenticated-orcid":false,"given":"Patrick","family":"Stargardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-0601","authenticated-orcid":false,"given":"Anne","family":"Ljungars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-3250","authenticated-orcid":false,"given":"David","family":"Scheich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-6991","authenticated-orcid":false,"given":"Nico","family":"Lingg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9923-9711","authenticated-orcid":false,"given":"Emil S.","family":"Elmose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4131-583X","authenticated-orcid":false,"given":"Shirin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5441-6402","authenticated-orcid":false,"given":"Florian","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-7728","authenticated-orcid":false,"given":"Alois","family":"Jungbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-1971","authenticated-orcid":false,"given":"Juergen","family":"Mairhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-5574","authenticated-orcid":false,"given":"Andreas H.","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2026.02.022_bb0005","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0010","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3389\/fimmu.2019.01598","article-title":"History of envenoming therapy and current perspectives","volume":"10","author":"Pucca","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0015","doi-asserted-by":"crossref","unstructured":"Laustsen, A.H. et al. From fangs to pharmacology: the future of snakebite envenoming therapy. Curr. Pharm. Des. 22, 5270\u20135293","DOI":"10.2174\/1381612822666160623073438"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.it.2024.03.001","article-title":"Recombinant snake antivenoms get closer to the clinic","volume":"45","author":"Laustsen","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pharmtox-022024-033544","article-title":"Progress and challenges in the field of snakebite envenoming therapeutics","volume":"65","author":"Guti\u00e9rrez","year":"2025","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0035","doi-asserted-by":"crossref","unstructured":"Thumtecho, S. et al. Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies. J. Venom. Anim. Toxins Trop. Dis. 29, e20230057","DOI":"10.1590\/1678-9199-jvatitd-2023-0057"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400348","article-title":"Single-batch expression of an experimental recombinant snakebite antivenom based on an oligoclonal mixture of human monoclonal antibodies","volume":"19","author":"Adams","year":"2024","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2085536","article-title":"In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom","volume":"14","author":"Ledsgaard","year":"2022","journal-title":"MAbs"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk1867","article-title":"Synthetic development of a broadly neutralizing antibody against snake venom long-chain \u03b1-neurotoxins","volume":"16","author":"Khalek","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0055","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-018-06086-4","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0060","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain \u03b1-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069495","article-title":"In vivo neutralization of \u03b1-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc Antibody","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0070","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-024-48539-z","article-title":"In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model","volume":"15","author":"Benard-Valle","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1263\/jbb.99.303","article-title":"Solubilization and refolding of bacterial inclusion body proteins","volume":"99","author":"Singh","year":"2005","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2004.11.003","article-title":"Recombinant protein secretion in Escherichia coli","volume":"23","author":"Mergulh\u00e3o","year":"2005","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000274","article-title":"Inhibition of E. coli host RNA polymerase allows efficient extracellular recombinant protein production by enhancing outer membrane leakiness","volume":"16","author":"Kastenhofer","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461649","article-title":"Proteomics analysis of host cell proteins after immobilized metal affinity chromatography: influence of ligand and metal ions","volume":"1633","author":"Lingg","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005361","article-title":"Recombinant snakebite antivenoms: a cost-competitive solution to a neglected tropical disease?","volume":"11","author":"Laustsen","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fbioe.2020.00703","article-title":"Cost of manufacturing for recombinant snakebite antivenoms","volume":"8","author":"Jenkins","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0115","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/acssynbio.0c00028","article-title":"Bacteriophage inspired growth-decoupled recombinant protein production in Escherichia coli","volume":"9","author":"Stargardt","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12934-021-01512-7","article-title":"Tunable expression rate control of a growth-decoupled T7 expression system by l-arabinose only","volume":"20","author":"Stargardt","year":"2021","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nbt.2018.04.006","article-title":"Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: a case study prior to pharmaceutical development","volume":"44","author":"Lebozec","year":"2018","journal-title":"New Biotechnol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2025.106805","article-title":"Efficient and economical purification platform for production of therapeutic nanobodies","volume":"236","author":"Metya","year":"2025","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2022.106991","article-title":"Neutralization capacity of recombinant antivenoms based on monoclonal antibodies and nanobodies","volume":"222","author":"Ljungars","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012833","article-title":"Target product profiles for pan-Africa recombinant antivenoms against neurotoxic or hemotoxic and cytotoxic snakebite envenoming","volume":"19","author":"Laustsen","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0145","series-title":"Snakebite envenoming \u2013 a strategy for prevention and control","author":"WHO Team for Control of Neglected Diseases","year":"2019"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","article-title":"Beyond BRCA: new hereditary breast cancer susceptibility genes","volume":"41","author":"Economopoulou","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.coche.2013.08.005","article-title":"Back to the future: recombinant polyclonal antibody therapeutics","volume":"2","author":"Wang","year":"2013","journal-title":"Curr. Opin. Chem. Eng."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0160","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1517\/14712598.2015.1042362","article-title":"Oligoclonal antibodies to target the ErbB family","volume":"15","author":"D\u2019Souza","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0165","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates","volume":"218","author":"Pascal","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0170","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.yexcr.2012.03.004","article-title":"Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells","volume":"318","author":"Jamnani","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0175","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12033-012-9601-0","article-title":"Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen","volume":"54","author":"Sharifzadeh","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/1547691X.2018.1526234","article-title":"Oligoclonal selection of nanobodies targeting vascular endothelial growth factor","volume":"16","author":"Ahadi","year":"2019","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41522-024-00514-8","article-title":"Protecting the piglet gut microbiota against ETEC-mediated post-weaning diarrhoea using specific binding proteins","volume":"10","author":"Jenkins","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40104-025-01209-6","article-title":"In-feed provision of binding proteins sustains piglet gut health and mitigates ETEC-induced post-weaning diarrhea","volume":"16","author":"Xu","year":"2025","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0200","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012628","article-title":"A combination of two human monoclonal antibodies cures symptomatic rabies","volume":"12","author":"de Melo","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0205","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s40064-015-1313-z","article-title":"Fed-batch like cultivation in a micro-bioreactor: screening conditions relevant for Escherichia coli based production processes","volume":"4","author":"Toeroek","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymben.2016.05.007","article-title":"Modular co-culture engineering, a new approach for metabolic engineering","volume":"37","author":"Zhang","year":"2016","journal-title":"Metab. Eng."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.mec.2019.e00110","article-title":"Developing E. coli-E. coli co-cultures to overcome barriers of heterologous tryptamine biosynthesis","volume":"10","author":"Wang","year":"2020","journal-title":"Metab. Eng. Commun."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0220","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1111\/1462-2920.13767","article-title":"Cooperation in microbial communities and their biotechnological applications","volume":"19","author":"Cavaliere","year":"2017","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0225","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1007\/s00253-016-7388-9","article-title":"Advances in recombinant antibody manufacturing","volume":"100","author":"Kunert","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001670","article-title":"Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context","volume":"6","author":"Brown","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-1656(99)00185-6","article-title":"Endotoxin removal from protein solutions","volume":"76","author":"Petsch","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s42004-025-01600-4","article-title":"Structural mechanisms behind the neutralisation of long-chain \u03b1-neurotoxins by broadly neutralising VHHs discovered using a consensus antigen","volume":"8","author":"Damsbo","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.tibtech.2026.02.022_bb0245","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2522838","article-title":"Discovery of broadly neutralizing VHHs against short-chain \u03b1-neurotoxins using a consensus toxin as an antigen","volume":"17","author":"Damsbo","year":"2025","journal-title":"MAbs"},{"key":"10.1016\/j.tibtech.2026.02.022_bb0250","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41586-025-09661-0","article-title":"Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites","volume":"647","author":"Ahmadi","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.02.022_bb2005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12934-024-02446-6","article-title":"A production platform for disulfide-bonded peptides in the periplasm of Escherichia coli","volume":"23","author":"Gibisch","year":"2024","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.tibtech.2026.02.022_bb2010","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800637","article-title":"Microbioreactor cultivations of fab-producing Escherichia coli reveal genome-integrated systems as suitable for prospective studies on direct fab expression effects","volume":"14","author":"Fink","year":"2019","journal-title":"Biotechnol. J."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:47:25Z","timestamp":1791496045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779926000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0167779926000855"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.02.022","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-pot expression of an oligoclonal nanobody-based antivenom in growth-decoupled Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}